近十年全球肺癌放疗研究现状及发展趋势——基于Web of Science文献计量学分析

doi:10.3760/cma.j.cn113030-20200331-00147

Abstract
Figure/Table
References(21)
Related Citation (15)
Read Tracking
Download Tracking

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Abstract Objective To investigate the research status and development trend of radiotherapy for lung cancer in recent 10 years through the bibliometric analysis of relevant literature. Methods Taking the core collection of Web of Science as the data source,combined with the visualization function of Cite Space software,bibliometric methods were adopted to analyze the literature publication,distribution of journals,authors,institutions and countries,the literature co-citation,keyword co-occurrence and clustering of the lung cancer radiotherapy research from 2010 to 2019. Results In recent 10 years,the amount of literature published in this field has been on the rise year by year. International Journal of Radiation Oncology Biology Physics was the journal with the largest number of publications. The authors and organizations with the most articles were all from the United States. Stereotactic radiotherapy has become a research hot spot in this field,and the combination of immunotherapy and stereotactic radiotherapy may become a novel development trend in the future. Conclusions In the past 10 years,the research on radiotherapy has been developing steadily at home and abroad,forming a certain research direction and development trend. Some core institutions and core authors have appeared. However, international exchange and cooperation remain to be strengthened probably due to the unbalanced development of global radiotherapy technology.

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Duan Hexin
	Xiang Zhibi
	Peng Haiqin
	Zhou Rongrong

Key words： Lung neoplasm/radiotherapy Bibliometrics Visualization analysis

Received: 31 March 2020

Fund:National Natural Science Foundation of China (81770928);Natural Science Foundation of Hunan Province (2018JJ2626)

Corresponding Authors: Zhou Rongrong,Email:664990095@qq.com

Cite this article:

Duan Hexin,Xiang Zhibi,Peng Haiqin et al. Research status and development trend of global radiotherapy for lung cancer in recent 10 years——bibliometric analysis based on Web of Science[J]. Chinese Journal of Radiation Oncology, 2020, 29(6): 401-406.

URL:

http://journal12.magtechjournal.com/Jweb_fszlx/EN/10.3760/cma.j.cn113030-20200331-00147 OR http://journal12.magtechjournal.com/Jweb_fszlx/EN/Y2020/V29/I6/401

[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424. DOI:10.3322/caac.21492.
[2] Kong FM, Zhao J, Wang J, et al. Radiation dose effect in locally advanced non-small cell lung cancer[J]. J Thorac Dis, 2014, 6(4):336-347. DOI:10.3978/j.issn.2072-1439.2014.01.23.
[3] 高俊宽. 文献计量学方法在科学评价中的应用探讨[J]. 图书情报知识, 2005,(2):14-17. DOI:10.3969/j.issn.1003-2797.2005.02.004.
Gao JK. Application of Bibliometrics Methods in Scientific Evaluation[J]. Document, Informaiton& Knowledge, 2005,(2):14-17. DOI:10.3969/j.issn.1003-2797.2005.02.004.
[4] 陈悦, 陈超美, 刘则渊, 等. CiteSpace知识图谱的方法论功能[J]. 科学学研究, 2015, 33(2):242-253. DOI:10.3969/j.issn.1003-2053.2015.02.009.
Chen Y, Chen CM, Liu ZY, et al. The methodology function of CiteSpace mapping knowledge domains[J]. Studies in Science of Science, 2015, 33(2):242-253. DOI:10.3969/j.issn.1003-2053.2015.02.009.
[5] 邹建军, 苏珊, 张贤兰, 等.2004年-2013年肺癌患病风险基因相关临床研究文献的计量学分析[J]. 分子诊断与治疗杂志, 2015, 7(4):236-240. DOI:10.3969/j.issn.1674-6929.2015.04.004.
Zou JJ, Su S, Zhang XL, et al. Bibliometrics analysis of clinical research literature on lung cancer predisposing genes from 2004 to 2013[J]. Journal of Molecular Diagnostics and Therapy, 2015, 7(4):236-240. DOI:10.3969/j.issn.1674-6929.2015.04.004.
[6] 应倩, 夏庆民, 狄笛, 等. 基于科学引文索引数据库的肺癌转化医学研究文献计量学分析[J]. 转化医学杂志, 2015(1):16-20. DOI:10.3969/j.issn.2095-3097.2015.01.005.
Ying Q, Xia QM, Di D, et al. An analysis for status of lung cancer translational research based on science citation index database[J]. Translational Medicine Journal, 2015,(1):16-20. DOI:10.3969/j.issn.2095-3097.2015.01.005.
[7] Ho YS, Nakazawa K, Sato S, et al. Cisplatin for small cell lung cancer:associated publications in Science Citation Index Expanded[J]. OncolLett, 2013, 5(2):684-688. DOI:10.3892/ol.2012.1029.
[8] 樊东升, 凌曦, 赵志刚, 等. 非小细胞肺癌靶向治疗研究的分析[J]. 中国临床药理学杂志, 2018, 34(14):1707-1709. DOI:10.13699/j.cnki.1001-6821.2018.14.035.
Fan DS, Ling X, Zhao ZG, et al. Analysis of the targeted therapy of non-small cell lung cancer[J]. The Chinese Journal of Clinical Pharmacology, 2018, 34(14):1707-1709. DOI:10.13699/j.cnki.1001-6821.2018.14.035.
[9] He XR, Han SY, Li PP. Recent highlights of Chinese medicine for advanced lung cancer[J]. Chin J Integr Med, 2017, 23(5):323-330. DOI:10.1007/s11655-016-2736-2.
[10] Haasbeek CJ, Lagerwaard FJ, Antonisse ME, et al. stage Ⅰ nonsmall cell lung cancer in patients aged> OR= 75 years:outcomes after stereotactic radiotherapy[J]. Cancer, 2010, 116(2):406-414. DOI:10.1002/cncr.24759.
[11] Li XP, Xiao JP, Chen XJ, et al. Fractionated stereotactic radiotherapy for small-cell lung cancer patients with brain metastases[J]. J Cancer Res Ther, 2014, 10(3):597-602. DOI:10.4103/0973-1482.137964.
[12] Singh D, Chen Y, Hare MZ, et al. Local control rates with five-fraction stereotactic body radiotherapy for oligometastatic cancer to the lung[J]. J Thorac Dis, 2014, 6(4):369-374. DOI:10.3978/j.issn.2072-1439.2013.12.03.
[13] Yamamoto T, Jingu K, Shirata Y, et al. Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors[J]. BMC Cancer, 2014, 14:464. DOI:10.1186/1471-2407-14-464.
[14] Agolli L, Valeriani M, Nicosia L, et al. Stereotactic ablative body radiotherapy (SABR) in pulmonary oligometastatic/oligorecurrent non-small cell lung cancer patients:a new therapeutic approach[J]. Anticancer Res, 2015, 35(11):6239-6245.
[15] Celik E, Semrau R, Baues C, et al. Robot-assisted extracranial stereotactic radiotherapy of adrenal metastases in oligometastatic non-small cell lung cancer[J]. Anticancer Res, 2017, 37(9):5285-5291. DOI:10.21873/anticanres.11954.
[16] Desideri I, Francolini G, Scotti V, et al. Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer[J]. ClinTransl Oncol, 2019, 21(7):933-938. DOI:10.1007/s12094-018-02005-7.
[17] Shukuya T, Takahashi T, Naito T, et al. Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failure[J]. Lung Cancer, 2011, 74(3):457-461. DOI:10.1016/j.lungcan.2011.04.007.
[18] Inomata M, Shukuya T, Takahashi T, et al. Continuous administration of EGFR-TKIs following radiotherapy after disease progression in bone lesions for non-small cell lung cancer[J]. Anticancer Res, 2011, 31(12):4519-4523.
[19] Herter-Sprie GS, Koyama S, Korideck H, et al. Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer[J]. JCI Insight, 2016, 1(9):e87415. DOI:10.1172/jci.insight.87415.
[20] 赵蓉英, 许丽敏. 文献计量学发展演进与研究前沿的知识图谱探析[J]. 中国图书馆学报, 2010, 36(5):60-68.
Zhao RY, Xu LM. An analysis of the knowledge map of the development evolution and research frontier of bibliometrics[J]. Journal of Library Science in China, 2010, 36(5):60-68.
[21] 李爱群, 黄玉舫, 邱均平. 我国学术期刊文献计量评价体系的客观性与评价结果的准确性探讨[J]. 中国科技期刊研究, 2009, 20(4):609-613.
Li AQ, Huang YF, Qiu JP. On objectivity and accuracy in evaluating Chinese academic journal documents by bibliometric system[J]. Chinese Journal of Scientificand Technical Periodical, 2009, 20(4):609-613.